{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:57:35Z","timestamp":1790225855340,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2005]]},"DOI":"10.1007\/s10156-005-0385-z","type":"journal-article","created":{"date-parts":[[2005,8,29]],"date-time":"2005-08-29T21:14:08Z","timestamp":1125350048000},"page":"189-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"title":["HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb"],"prefix":"10.1016","volume":"11","author":[{"given":"Cesare","family":"Sarrecchia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cappelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Sarrecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s10156-005-0385-Z_bib0005","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patientsundergoing cytotoxic chemotherapy: a prospective study of 626patients with identification of risk factors","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"key":"10.1007\/s10156-005-0385-Z_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1034\/j.1600-0609.2001.067001045.x","article-title":"Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies","volume":"67","author":"Kawatani","year":"2001","journal-title":"Eur J Haematol"},{"key":"10.1007\/s10156-005-0385-Z_bib0015","first-page":"ECR22","article-title":"Fulminant hepatitis subsequent to reactivation of precore mutant hepatitis B virus in a patient with lymphoma treated with chemotherapy and rituximab","volume":"88","author":"Hernand\u00e9z","year":"2003","journal-title":"Haematologica"},{"key":"10.1007\/s10156-005-0385-Z_bib0020","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1038\/sj.leu.2402567","article-title":"Treatment of HBV-carrying lymphoma patients with rituximab and CHOP: a diagnostic and therapeutic challenge","volume":"16","author":"Skrabs","year":"2002","journal-title":"Leukemia"},{"key":"10.1007\/s10156-005-0385-Z_bib0025","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V99.2.724","article-title":"Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis-B virus infected patients treated for non-Hodgkin's lymphoma","volume":"99","author":"Persico","year":"2002","journal-title":"Blood"},{"key":"10.1007\/s10156-005-0385-Z_bib0030","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V100.2.391","article-title":"Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface carriers","volume":"100","author":"Shibolet","year":"2002","journal-title":"Blood"},{"key":"10.1007\/s10156-005-0385-Z_bib0035","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/104281903100006351","article-title":"Prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HBsAg carriers with hemato-oncological neoplasia treated with chemotherapy","volume":"44","author":"Rossi","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1007\/s10156-005-0385-Z_bib0040","unstructured":"Medscape Alert Oct 9, 2004. Rituximab may be associated with HBV reactivation and fulminant hepatitis. http:\/\/www.medscape.com\/infectiousdiseases. Cited Oct, 9, 2004."},{"key":"10.1007\/s10156-005-0385-Z_bib0045","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1007\/s10156-005-0385-Z_bib0050","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1182\/blood-2003-05-1403","article-title":"Fatal hepatitis B virus reactivationby an escape mutant following rituximab therapy","volume":"102","author":"Westhoff","year":"2003","journal-title":"Blood"},{"key":"10.1007\/s10156-005-0385-Z_bib0055","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/hep.510270638","article-title":"Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen","volume":"27","author":"Mason","year":"1998","journal-title":"Hepatology"},{"key":"10.1007\/s10156-005-0385-Z_bib0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tracli.2003.11.007","article-title":"Occult hepatitis B infection","volume":"11","author":"Allain","year":"2004","journal-title":"Transfus Clin Biol"},{"key":"10.1007\/s10156-005-0385-Z_bib0065","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(95)92599-6","article-title":"Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA","volume":"345","author":"Carman","year":"1995","journal-title":"Lancet"},{"key":"10.1007\/s10156-005-0385-Z_bib0070","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3748\/wjg.v9.i7.1516","article-title":"A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis","volume":"9","author":"Yang","year":"2003","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X05709879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X05709879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10156-005-0385-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:44:14Z","timestamp":1761158654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X05709879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"alternative-id":["S1341321X05709879"],"URL":"https:\/\/doi.org\/10.1007\/s10156-005-0385-z","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2005]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s10156-005-0385-Z","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Japanese Society of Chemotherapy and the Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}